Detalles de la búsqueda
1.
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer.
Lung
; 202(2): 197-210, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38480620
2.
Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity.
Int J Mol Sci
; 25(1)2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38203395
3.
Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis.
Breast Cancer Res Treat
; 191(2): 269-275, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34731351
4.
Serum levels of VCAM-1 are associated with survival in patients treated with nivolumab for NSCLC.
Eur J Clin Invest
; 52(1): e13668, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34390488
5.
Biological Rationale for Peripheral Blood Cell-Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer.
Curr Oncol Rep
; 24(12): 1851-1862, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36255605
6.
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
Lancet Oncol
; 22(12): 1669-1680, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34741822
7.
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.
Int J Mol Sci
; 22(5)2021 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33807876
8.
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak.
Eur J Clin Invest
; 50(9): e13315, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32535890
9.
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study.
Cancer Immunol Immunother
; 68(8): 1351-1358, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31327024
10.
Heterogeneity of treatment effects in malignant pleural mesothelioma.
Lancet
; 398(10297): 301-302, 2021 07 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34303435
11.
Comment on "Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and metaanalysis".
Breast Cancer Res Treat
; 194(3): 709-710, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35739368
12.
Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma.
J Thorac Oncol
; 19(1): 166-172, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37567387
13.
CD34+DNAM-1brightCXCR4+ haemopoietic precursors circulate after chemotherapy, seed lung tissue and generate functional innate-like T cells and NK cells.
Front Immunol
; 15: 1332781, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38390333
14.
EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers.
NPJ Precis Oncol
; 8(1): 37, 2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38366021
15.
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients.
NPJ Precis Oncol
; 8(1): 51, 2024 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38409229
16.
Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
Clin Lung Cancer
; 25(3): 233-243.e8, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38105153
17.
Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey.
JTO Clin Res Rep
; 4(1): 100446, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36687558
18.
Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.
Eur J Cancer
; 182: 107-114, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36758475
19.
Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Cells
; 12(6)2023 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980174
20.
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.
Lung Cancer
; 178: 116-122, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36812760